Dr. Alan Gaby author of the textbook Nutrition Bible for medical and natural health practitioners - Vitamin C right dose supplementation the can help with the following health conditions:
Table 22-1. Vitamin C may be useful for preventing and/or treating the following conditions
Vitamin C may be useful for preventing and/or treating a wide range of conditions, as listed in Table 22-1.
Absorption and excretion
Fractional absorption of vitamin C decreases with increasing oral intake. When 15–30 mg of vitamin C was administered, approximately 90% was absorbed. In contrast, less than 50% was absorbed when the dose was increased to 1,250 mg.
Atherosclerosis/ischemic heart disease Hypertension
Immune thrombocytopenic purpura Prickly heat
Ear, nose, and throat
Sudden sensorineural hearing loss
Constipation Gallstones Gastritis Peptic ulcer
Acquired immunode ciency syndromeColds
Infectious mononucleosis Tuberculosis
Urinary tract infection
Paget’s disease (osteitis deformans) Complex regional pain syndrome
Obstetrical and gynecological
Dysfunctional uterine bleeding Leg cramps of pregnancy Premature rupture of membranes
Conjunctivitis Glaucoma Uveitis
Critical illness Diabetes Gingivitis Hepatitis Hypoadrenalism Infertility Obesity
Opioid addiction Post-exercise muscle soreness
16. Pauling L. Evolution and the need for ascorbic acid. Proc Natl Acad Sci 1970;67:1643–1648.
17. Blanchard J, Tozer TN, Rowland M. Pharmacokinetic perspectives on megadoses of ascorbic acid. Am J Clin Nutr 1997;66:1165–1171.
18. Spector R. Vitamin homeostasis in the central nervous system. N Engl J Med 1977;296:1393–1398.
19. Pauling L. Vitamin homeostasis in the brain and megavitamin therapy. N Engl J Med 1977;297:790–791.
20. Tsao CS, Salimi SL. Evidence of rebound effect with ascorbic acid. Med Hypotheses 1984;13:303–310.
21. Schleicher RL, Carroll MD, Ford ES, Lacher DA. Serum vitamin Cand the prevalence of vitamin C de ciency in the United States: 2003–2004National Health and Nutrition Examination Survey (NHANES). Am J Clin Nutr 2009;90:1252–1263.
22. Levine M, Katz A, Padayatty SJ. Vitamin C. In Shils ME, Shike M, Ross AC, et al (eds.). Modern Nutrition in Health and Disease, Tenth Edition. Balti- more, MD, Lippincott Williams & Wilkins, 2006:507–524.
23. Vobecky JS, Vobecky J, Shapcott D, Blanchard R. Vitamin E and C levelsin infants during the rst year of life. Am J Clin Nutr 1976;29:766–771.
24. Hiebert CA. Gastroesophageal re ux and ascorbic acid insuf ciency. AnnThorac Surg 1977;24:108–112.
25. Thomas AJ, Briggs RS, Monro P. Is leucocyte ascorbic acid an unreliableestimate of vitamin C de ciency? Age Ageing 1984;13:243–247.
26. Barton GMG, Roath OS. Leucocyte ascorbic acid in abnormal leucocyte states. Int J Vitam Nutr Res 1976;46:271–274.
27. Burch HB. Methods for detecting and evaluating ascorbic acid de ciency inman and animals. Ann N Y Acad Sci 1961;92:268–276.
28. Duncan A, Talwar D, McMillan DC, et al. Quantitative data on the magni-tude of the systemic in ammatory response and its effect on micronutrient statusbased on plasma measurements. Am J Clin Nutr 2012;95:64–71.
29. Auer BL, Auer D, Rodgers AL. Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 1998;28: 695–700.
30. Sunkara V, Pelkowski TD, Dreyfus D, Satoskar A. Acute kidney disease due to excessive vitamin C ingestion and remote Roux-en-Y gastric bypass sur- gery superimposed on CKD. Am J Kidney Dis 2015;66:721–724.
31. Lawton JM, Conway LT, Crosson JT, et al. Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med 1985;145:950–951.
32. Wong K, Thomson C, Bailey RR, et al. Acute oxalate nephropathy after a massive intravenous dose of vitamin C. Aust N Z J Med 1994;24:410–411.
33. McAllister CJ, Scowden EB, Dewberry FL, Richman A. Renal failure sec- ondary to massive infusion of vitamin C. JAMA 1984;252:1684.
34. Swartz RD, Wesley JR, Somermeyer MG, Lau K. Hyperoxaluria and renalinsuf ciency due to ascorbic acid administration during total parenteral nutri- tion. Ann Intern Med 1984;100:530–531.
35. Mashour S, Turner JF Jr, Merrell R. Acute renal failure, oxalosis, and vitamin C supplementation: a case report and review of the literature. Chest 2000;118:561–563.
36. Slivka A, Kang JO, Cohen G. Ascorbic acid. N Engl J Med 1986;315:708– 709.
37. Rees DC, Kelsey H, Richards JDM. Acute haemolysis induced by highdose ascorbic acid in glucose-6-phosphate dehydrogenase de ciency. BMJ1993;306:841–842.
38. Campbell GD Jr, Steinberg MH, Bower JD. Ascorbic acid induced hemoly-sis in G-6-PD de ciency. Ann Intern Med 1975;82:810.
39. Huang YC, Chang TK, Fu YC, Jan SL. C for colored urine: acute hemolysis induced by high-dose ascorbic acid. Clin Toxicol 2014;52:984.
40. Pereyo N. Tartrazine compounds. Arch Dermatol 1979;115:508.
41. Gordonoff T. Water-soluble vitamins in excessive doses. JAMA 1960; 174:1672.
42. Cathcart RF III. Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy. Med Hypotheses 1981;7:1359–1376.
43. Cochrane WA. Overnutrition in prenatal and neonatal life: a problem? CanMed Assoc J 1965;93:893–899.
44. Demers P, Fraser D, Goldbloom R, et al. An epidemiological study of infan- tile scurvy in Canada: 1961–63. Can Med Assoc J 1965;93:573–576.
45. Stone I, Hoffer A. The genesis of medical myths. J Orthomolec Psychiatry 1976;5:163–168.
46. Carpenter KJ. Vitamin de ciencies in North America in the 20th century.Nutr Today 1999;34(6):223–228.
47. Giunta JL. Dental erosion resulting from chewable vitamin C tablets. J Am Dent Assoc 1983;107:253–256.
48. Meurman JH, Murtomaa H. Effect of effervescent vitamin C preparations on bovine teeth and on some clinical and salivary parameters in man. Scand J Dent Res 1986;94:491–499.
49. Dannenberg JL. Vitamin C enamel loss. J Am Dent Assoc 1982;105:172–173.50. Bahal P, Djemal S. Dental erosion from an excess of vitamin C. Case Rep Dent 2014;2014:485387.
51. van Campen D, Gross E. In uence of ascorbic acid on the absorption ofcopper by rats. J Nutr 1968;95:617–622.
52. Johnson MA, Murphy CL. Adverse effects of high dietary iron and ascorbicacid on copper status in copper-de cient and copper-adequate rats. Am J ClinNutr 1988;47:96–101.
53. Hunt CE, Carlton WW. Cardiovascular lesions associated with experimen-tal copper de ciency in the rabbit. J Nutr 1965;87:385–393.
54. Disilvestro RA, Harris ED. A postabsorption effect of L-ascorbic acid on copper metabolism in chicks. J Nutr 1981;111:1964–1968.
55. Jacob RA, Skala JH, Omaye ST, Turnlund JR. Effect of varying ascorbic acid intakes on copper absorption and ceruloplasmin levels of young men. J Nutr 1987;117:2109–2115.
56. Finley EB, Cerklewski FL. In uence of ascorbic acid supplementation oncopper status in young adult men. Am J Clin Nutr 1983;37:553–556.
57. Chenoweth W, Ducey S, Ullrey D. Effect of dietary copper and ascorbic acid supplementation on copper and zinc balances in elderly men. Fed Proc 1984;43:683.
58. Clemetson CAB, Andersen L. Plant polyphenols as antioxidants for ascor- bic acid. Ann N Y Acad Sci 1966;136:341–376.
59. Ambrose AM, DeEds F. The value of rutin and quercetin in scurvy. J Nutr 1949;38:305–317.
60. Chen LH. An increase in vitamin E requirement induced by high supple- mentation of vitamin C in rats. Am J Clin Nutr 1981;34:1036–1041.
61. Brown KM, Morrice PC, Duthie GG. Erythrocyte vitamin E and plasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and nonsmokers: dose response to vitamin E supplementation. Am J Clin Nutr 1997;65:496–502.
62. Robinson MF, Thomson CD, Huemmer PK. Effect of a megadose of ascor- bic acid, a meal and orange juice on the absorption of selenium as sodium sele- nite. N Z Med J 1985;98:627–629.
63. Martin RF, Young VR, Blumberg J, Janghorbani M. Ascorbic acid-selenite interactions in humans studied with an oral dose of 74SeO3(2-). Am J Clin Nutr 1989;49:862–869.
64. Ip C. Interaction of vitamin C and selenium supplementation in the modi - cation of mammary carcinogenesis in rats. J Natl Cancer Inst 1986;77:299–303.65. O’Gorman P, Grif ths PD, Bloxam HR. Ascorbic acid inhibition of theglucose-oxidase test for glycosuria. Br Med J 1960;1:603–606.
66. Mayson JS, Schumaker O, Nakamura RM. False negative tests for urinary glucose in the presence of ascorbic acid. Am J Clin Pathol 1972;58:297–299.67. Mayson JS, Schumaker O, Nakamura RM. False-negative tests for urine glucose. Lancet 1973;1:780–781.
68. Maguire GA, Price CP. Evidence for interference by ascorbate in the mea-surement of cerebrospinal uid glucose by a kinetic glucose oxidase/peroxidaseprocedure. Clin Chem 1983;29:1810–1812.
69. Nahata MC, McLeod DC. Noneffect of oral urinary copper ascorbic acid on reduction glucose test. Diabetes Care 1978;1:34–35.
70. Smith D, Young WW. Effect of large-dose ascorbic acid on the two drop Clinitest determination. Am J Hosp Pharm 1977;34:1347–1349.
71. Nahata MC, McLeod DC. Lack of effect of ascorbic acid, hippuric acid, and methenamine (urinary formaldehyde) on the copper-reduction glucose test in geriatric patients. J Am Geriatr Soc 1980;28:230–233.
72. Wandzilak TR, D’Andre SD, Davis PA, Williams HE. Effect of high dose vitamin C on urinary oxalate levels. J Urol 1994;151:834–837.
73. Chalmers AH, Cowley DM, McWhinney BC. Stability of ascorbate in urine: relevance to analyses for ascorbate and oxalate. Clin Chem 1985;31:1703–1705.74. Jaffe RM, Kasten B, Young DS, MacLowry JD. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 1975;83:824–826.
75. Jaffe RM, Lawrence L, Schmid A, MacLowry JD. Inhibition by ascorbic acid (vitamin C) of chemical detection of blood in urine. Am J Clin Pathol 1979;72:468–470.
76. Benzie IFF, Strain JJ. The effect of ascorbic acid on the measurement of total cholesterol and triglycerides: possible artefactual lowering in individuals with high plasma concentration of ascorbic acid. Clin Chim Acta 1995;239:185–190.77. Badrick TC, Campbell B. Effects of intravenous infusion of ascorbate on common clinical chemistry tests. Clin Chem 1992;38:2160.
78. Hallberg L, Rossander L, Persson H, Svahn E. Deleterious effects of pro- longed warming of meals on ascorbic acid content and iron absorption. Am J Clin Nutr 1982;36:846–850.
79. Oregon State University. Linus Pauling Institute. http://lpi.oregonstate.edu/ infocenter/vitamins/vitaminC. Accessed April 23, 2010.
80. Ruskin SL. Sodium ascorbate in the treatment of allergic disturbances. The role of adrenal cortical hormone-sodium-vitamin C. Am J Dig Dis 1947; 14:302–306.
81. Vinson JA, Bose P. Comparative bioavailability to humans of ascorbic acid alone or in a citrus extract. Am J Clin Nutr 1988;48:601–604.
82. Johnston CS, Luo B. Comparison of the absorption and excretion of three commercially available sources of vitamin C. J Am Diet Assoc 1994;94:779– 781.
83. Cathcart RF. Vitamin C: the nontoxic, nonrate-limited, antioxidant free rad- ical scavenger. Med Hypotheses 1985;18:61–77.
Information and statements regarding dietary supplements/products have not been evaluated by the TGA and are not intended to diagnose, treat, cure, or prevent any disease. Information on this website is provided for informational purposes only and is a result of years of practice and experience by the author. This information is not intended as a substitute for the advice provided by your physician or other healthcare professional or any information contained on or in any product label or packaging. Do not use the information on this website for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal, or homeopathic supplement, or using any treatment for a health problem. If you have or suspect that you have a medical problem, contact your healthcare provider promptly. Do not disregard professional medical advice or delay in seeking professional advice because of something you have read on this website